CIK 0000315545
- Non-accelerated filer
- Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900031917
- Phone
- +1 866-594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 53 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-04-12 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options (Right to Buy) | −100,000 | 300,000 | ||
| 2011-04-12 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Common Stock | −50,000 | 0 | ||
| 2011-02-07 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +8,333 | $0.75 | $6K | 3,776,570 |
| 2011-02-07 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options (Right to Buy) | +8,333 | 114,248 | ||
| 2011-02-03 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +125,000 | $0.75 | $94K | 3,768,237 |
| 2011-02-03 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options - Right to Buy | −125,000 | 122,581 | ||
| 2010-12-29 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +400,000 | $1.00 | $400K | 3,643,237 |
| 2010-12-29 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options (Right to Buy) | −400,000 | 400,000 | ||
| 2010-12-29 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +133,333 | $0.75 | $100K | 543,709 |
| 2010-12-29 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to buy) | −133,333 | 166,667 | ||
| 2010-11-19 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +100,000 | $1.00 | $100K | 3,243,237 |
| 2010-11-19 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Option (Right to Buy) | −100,000 | 800,000 | ||
| 2010-09-07 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +100,000 | $1.00 | $100K | 3,143,237 |
| 2010-09-07 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Common Stock | −100,000 | 900,000 | ||
| 2010-07-22 | SCOTT TIMOTHY PHD President | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2010-07-22 | DEES H CRAIG Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2010-07-22 | WACHTER ERIC PHD Vice President Pharmaceuticals | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2010-07-22 | CULPEPPER PETER R Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2010-07-09 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +75,000 | $1.10 | $83K | 3,043,237 |
| 2010-07-09 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options (right to buy) | −75,000 | 0 |
Page 20 of 28 · 553 trades